Publications

Learn more about our science.

June 2022

CRESTONE: Initial Efficacy and Safety of Seribantumab in Solid Tumors Harboring NRG1 Fusions

All
Posters & Oral Presentations
Manuscripts

April 06, 2021

Manuscripts

The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with oncogenic NRG1 fusions

Odintsov et al., Clinical Cancer Research 2021

March 29, 2021

Posters & Oral Presentations

CRESTONE – Clinical Study of REsponse to Seribantumab in TumOrs with NEuregulin-1 (NRG1) Fusions

Presented at SGO 2021

Presenting Author: Erika Hamilton, MD; Sarah Cannon Research Institute

January 15, 2021

Posters & Oral Presentations

CRESTONE – Clinical Study of REsponse to Seribantumab in TumOrs with NEuregulin-1 (NRG1) Fusions – A Phase 2 Study of the anti-HER3 mAb for Advanced or Metastatic Solid Tumors (NCT04383210)

Presented at ASCO GI 2021

Presenting Author: Johanna Bendell, MD; Sarah Cannon Research Institute

October 26, 2020

Posters & Oral Presentations

The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with NRG1 rearrangements

Presented at EORTC-NCI-AACR 2020

Presenting Author: Igor Odintsov, MD; Memorial Sloan Kettering Cancer Center

October 16, 2020

Posters & Oral Presentations

CRESTONE – Clinical Study of REsponse to Seribantumab in TumOrs with NEuregulin-1 (NRG1) Fusions – A Phase 2 Study of the anti-HER3 mAb for Advanced or Metastatic Solid Tumors (NCT04383210)

Presented at IASLC North America Conference on Lung Cancer 2020

Presenting Author: David Spigel, MD; Sarah Cannon Research Institute

September 29, 2020

Posters & Oral Presentations

CRESTONE – Clinical Study of REsponse to Seribantumab in TumOrs with NEuregulin-1 (NRG1) Fusions – A Phase 2 Study of the anti-HER3 mAb for Advanced or Metastatic Solid Tumors (NCT04383210)

Presented at AACR Special Conference on Pancreatic Cancer 2020

Presenting Author: Johanna Bendell, MD; Sarah Cannon Research Institute

Pages: 12

Track our progress

Check back often for our latest insights, or sign up for our mailing list to receive the have the latest news and publications from Elevation Oncology delivered to your inbox.